# Analysis of small extracellular vesicles from dried blood spots

**Authors:** Rikke Bæk, Jenni Kathrine Sloth, Mohammad Mehedi Hasan, Getnet Midekessa, Malene Møller Jørgensen

PMC · DOI: 10.3389/fmedt.2025.1494239 · Frontiers in Medical Technology · 2025-01-27

## TL;DR

This paper presents a detailed protocol for extracting small extracellular vesicles from dried blood spots, showing their potential for non-invasive diagnostics.

## Contribution

A robust and reliable method for sEV extraction from DBS, validated with multiple techniques and storage stability.

## Key findings

- Approximately 40% of sEVs were recovered from DBS compared to plasma.
- sEVs remained stable for up to 3 weeks of DBS storage.
- Multiple sEV markers were successfully detected using protein microarray.

## Abstract

This protocol paper describes how to extract small extracellular vesicles (sEVs) from dried blood spots (DBS). The methodology is described in detail and offers further evidence that the extracted particles are sEVs using western blotting (anti-CD9, CD63 and CD81) and fluorescence nanoparticle tracking analysis (fNTA). In addition, we present evidence that approximately 40% of the sEVs were recovered from DBS compared with EVs analyzed from plasma directly. The protocol proves to be robust, reliable and displays very interesting performances even after several weeks (up to 3 weeks) of storage of the DBS when analyzing the sEVs using protein microarray for the presence of the markers CD9, CD63, CD81, EpCAM, Flotilin-1, CD62E/P, CD142 and CD235a. These findings have important implications for using sEVs as future potential diagnostic tools by supporting the validity of less-invasive methods that can be implemented within vulnerable populations or in the field.

## Linked entities

- **Proteins:** CD9 (CD9 molecule), CD63 (CD63 molecule), CD81 (CD81 molecule), EPCAM (epithelial cell adhesion molecule), F3 (coagulation factor III, tissue factor), GYPA (glycophorin A (MNS blood group))

## Full-text entities

- **Genes:** CD9 (CD9 molecule) [NCBI Gene 928] {aka BTCC-1, DRAP-27, MIC3, MRP-1, TSPAN-29, TSPAN29}, F3 (coagulation factor III, tissue factor) [NCBI Gene 2152] {aka CD142, TF, TFA}, CD63 (CD63 molecule) [NCBI Gene 967] {aka AD1, HOP-26, ME491, MLA1, OMA81H, Pltgp40}, CD81 (CD81 molecule) [NCBI Gene 975] {aka CVID6, S5.7, TAPA1, TSPAN28}, EPCAM (epithelial cell adhesion molecule) [NCBI Gene 4072] {aka Ber-Ep4, BerEp4, DIAR5, EGP-2, EGP314, EGP40}, GYPA (glycophorin A (MNS blood group)) [NCBI Gene 2993] {aka CD235a, GPA, GPErik, GPSAT, HGpMiV, HGpMiXI}

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11808138/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11808138/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC11808138/full.md

---
Source: https://tomesphere.com/paper/PMC11808138